Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/18/18
End: 02/28/20
Due: 02/28/21
Phase: N/A
Priority: Normal
Start: 11/13/19
End: 01/11/21
Due: 01/11/22
Phase: N/A
Priority: Normal
Start: 02/01/20
End: 01/11/21
Due: 01/11/22
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 10/31/22
Due: 10/31/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Topical Preparation of Pomegranate and Ginkgo Biloba for Anti-aging Activities | NCT03772418 | Ahmed A. H. Abdellatif | user2@example.com | None | 2018-05-18 | 2020-02-28 | 2021-02-28 | - | - | 2025-07-14 |
| Topical Silver Nanoparticles for Microbial Activity | NCT03752424 | Ahmed A. H. Abdellatif | user2@example.com | None | 2019-11-13 | 2021-01-11 | 2022-01-11 | - | - | 2025-07-14 |
| Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer | NCT03774680 | Ahmed A. H. Abdellatif | user2@example.com | None | 2020-02-01 | 2021-01-11 | 2022-01-11 | - | - | 2025-07-14 |
| Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis | NCT02882438 | Ahmed A. H. Abdellatif | user2@example.com | None | 2016-01-31 | 2022-10-31 | 2023-10-31 | - | - | 2025-07-14 |